UGT1A3 plays an important role in intestinal and liver drug metabolism, participating in the metabolism of a variety of cancers, thus promoting the resistance of tumor cells to chemotherapy drugs (Preston Pugh et al., 2014; Liu et al., 2015). Here, UGT1A3 is linked to cancer.